(Q56965918)
Statements
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL (English)
0 references
28 September 2012
0 references
120
0 references
26
0 references
5185-5187
0 references